1700018F24Rik Activators encompass a diverse array of chemical compounds that enhance the activity of 1700018F24Rik through discrete signaling modalities. Forskolin and Isoproterenol, by increasing intracellular cAMP levels, indirectly heighten the activity of 1700018F24Rik by activating protein kinase A (PKA), which may phosphorylate and thus modulate the activity of 1700018F24Rik if it is a substrate or part of a PKA-regulated pathway. The direct activation of protein kinase C (PKC) by Phorbol 12-myristate 13-acetate (PMA) or the downstream effects of histamine could lead to the phosphorylation of proteins within signaling cascades that include 1700018F24Rik, thereby enhancing its functional activity. Ionomycin, by increasing intracellular calcium levels, and Thapsigargin, through the inhibition of the SERCA pump, potentially augment the activity of 1700018F24Rik via the activation of calcium-dependent kinases, assuming 1700018F24Rik is regulated by such calcium-mediated signaling.
Compounds such as Sphingosine-1-phosphate and Anandamide engage in their respective receptor-mediated signaling, leading to the activation of PI3K/Akt pathways, which might enhance the activity of 1700018F24Rik if it is modulated by these pathways. Growth factors like EGF and VEGF, known for their roles in activating MAPK and PI3K pathways, could also play a role in indirectly enhancing the activity of 1700018F24Rik by integrating it into their signaling networks. IBMX, through the inhibition of phosphodiesterases, leads to a sustained increase in cAMP and the persistent activation of PKA, which could result in the augmented activity of 1700018F24Rik. Lastly, LY294002, although a PI3K inhibitor, might indirectly heighten the activity of 1700018F24Rik by shifting the balance of cellular signaling towards alternative compensatory pathways that activate 1700018F24Rik, highlighting the intricate interplay within cellular signaling networks that can be leveraged to modulate protein function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of target proteins. If 1700018F24Rik is a substrate for PKC or part of a pathway regulated by PKC, its activity would be enhanced by this compound. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent kinases such as calmodulin-dependent kinase (CaMK). If 1700018F24Rik is part of a CaMK-regulated pathway, ionomycin could enhance its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) engages S1P receptors and can activate downstream signaling pathways such as PI3K/Akt. If 1700018F24Rik activity is modulated via these pathways, S1P could lead to its activation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through its G-protein-coupled receptors, can activate PLC, resulting in PKC activation. If 1700018F24Rik is influenced by PKC-mediated signaling, histamine could enhance its activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, leading to increased cytosolic calcium levels and activation of calcium-dependent signaling. This could activate 1700018F24Rik if it is calcium-regulated. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased cAMP levels and subsequent activation of PKA. If 1700018F24Rik is PKA-regulated, IBMX would enhance its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which paradoxically can enhance the activity of proteins in alternative compensatory pathways. If 1700018F24Rik is part of such a compensatory pathway, LY294002 could indirectly enhance its activity. | ||||||